Extended Data Fig. 5: Overview of number of regions sampled, stage, treatment and ITH metrics including mutational ITH, SCNA ITH and whole genome doubling status for 432 tumours from 421 patients in TRACERx. | Nature

Extended Data Fig. 5: Overview of number of regions sampled, stage, treatment and ITH metrics including mutational ITH, SCNA ITH and whole genome doubling status for 432 tumours from 421 patients in TRACERx.

From: The evolution of lung cancer and impact of subclonal selection in TRACERx

Extended Data Fig. 5: Overview of number of regions sampled, stage, treatment and ITH metrics including mutational ITH, SCNA ITH and whole genome doubling status for 432 tumours from 421 patients in TRACERx.

Each tumour is arranged vertically ordered first by pathological stage then by fraction of subclonal subclonal mutations. LCNEC = Large cell neuroendocrine carcinoma, CN = copy number.

Back to article page